MAPT and Alzheimer disease: Lower FA and higher MD in the CC have been reported in AD patients when compared with healthy volunteers (Bozzali et al., 2001) and more recent studies have found that reductions in the white matter FA in AD patients correlate with CSF AD biomarkers of total and phosphorylated tau (Amlien et al., 2013).